| AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer A Aytatli, N Barlak, F Sanli, HO Caglar, B Gundogdu, A Tatar, M Ittmann, ... Cellular Oncology, 1-16, 2022 | 19 | 2022 |
| ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer N Barlak, O Capik, F Sanli, A Kilic, A Aytatli, A Yazici, S Ortucu, M Ittmann, ... Cell Biology International 44 (1), 242-252, 2020 | 19 | 2020 |
| Mode of action of carboplatin via activating p53/miR‐145 axis in head and neck cancers A Kilic, N Barlak, F Sanli, A Aytatli, O Capik, OF Karatas The Laryngoscope 130 (12), 2818-2824, 2020 | 15 | 2020 |
| MicroRNA‐145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells N Barlak, O Capik, A Kilic, F Sanli, A Aytatli, A Yazici, EA Karatas, ... Cell Biology International 45 (5), 1082-1090, 2021 | 12 | 2021 |
| Design, Synthesis, and Biological Evaluation of Indole-Modified Tamoxifen Relatives as Potent Anticancer Agents B Ertugrul, A Aytatli, N Saracoglu, OF Karatas RSC Medicinal Chemistry, 2023 | 3 | 2023 |
| Current cancer stem cell biomarkers in tongue squamous cell carcinoma OF Karatas, S Teber, A Yilmaz, A Baltacioglu, SM Kilic, E Poyraz, A Aytatli, ... Trakya University Journal of Natural Sciences 19 (2), 197-207, 2018 | 3 | 2018 |
| The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells F Şanlı, N Barlak, A Kılınç, Ö Çapık, A Aytatlı, OF Karatas The European Research Journal 6 (5), 380-387, 2020 | 2 | 2020 |
| CDR1as/miR-7-5p/IGF1R axis contributes to the suppression of cell viability in prostate cancer M Kaya, I Suer, A Aytatli, OF Karatas, S Palanduz, K Cefle, S Ozturk Turkish Journal of Biochemistry, 2024 | | 2024 |
| In silico identification of differentially expressed microRNAs in thyroid cancer HO Caglar, A Aytatli, OF Karatas Human Gene, 201306, 2024 | | 2024 |
| Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer HO Caglar, A Aytatli, N Barlak, E Aydin Karatas, A Tatar, A Sahin, ... Head & Neck, 2024 | | 2024 |
